Methylenedioxybutylamphetamine

Last updated
MDBU
MDBU.svg
Clinical data
Other namesMDBU; 3,4-Methylenedioxy-N-butylamphetamine; N-Butyl-MDA
Routes of
administration 		Oral [1]
ATC code
  • None
Pharmacokinetic data
Duration of action Unknown [1]
Identifiers
  • N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]butan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C14H21NO2
Molar mass 235.327 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(C)NCCCC)OCO2
  • InChI=1S/C14H21NO2/c1-3-4-7-15-11(2)8-12-5-6-13-14(9-12)17-10-16-13/h5-6,9,11,15H,3-4,7-8,10H2,1-2H3
  • Key:RDXVRDCQDITVDV-UHFFFAOYSA-N

MDBU, also known as 3,4-methylenedioxy-N-butylamphetamine or as N-butyl-MDA, is a lesser-known drug. [1] [2] It is the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA). [1] [2]

Contents

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDBU's minimum dose as 40 mg orally and its duration as unknown. [1] [2] MDBU produces few to no effects. [1]

See also

References

  1. 1 2 3 4 5 6 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN   0-9630096-0-5. OCLC   25627628. MDBU entry
  2. 1 2 3 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN   978-0-12-433951-4. Archived from the original on 13 July 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.